Cargando…
Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics
BACKGROUND: Therapeutic approaches for cancer rely on careful consideration of finding the optimal way of delivering the pro-drug for cellular-based cancer treatment. Cell lines and cell cultures have been used in these studies to compare the in vitro and in vivo efficacy of autologous vs. allogenei...
Autores principales: | Zweiri, Jehad, Christmas, Stephen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986055/ https://www.ncbi.nlm.nih.gov/pubmed/32002015 http://dx.doi.org/10.1186/s12935-020-1115-4 |
Ejemplares similares
-
The impact of γ-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use
por: Zweiri, Jehad, et al.
Publicado: (2017) -
Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug
por: Cheng, T L, et al.
Publicado: (1999) -
The Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis Offers Efficient Bystander Cell Killing for Suicide Gene Therapy of Cancer
por: Sato, Takeya, et al.
Publicado: (2013) -
Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009) -
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
por: Zhu, Jialin, et al.
Publicado: (2020)